Dr. Stephen Worthley, Ph.D., director of the cardiac cath labs at Royal Adelaide Hospital at the University of Adelaide ...
Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for ...
Manesh Patel, M.D., associate professor of medicine, and director of interventional cardiology and the cath labs at Duke ...
October 27, 2015 — A large observational registry found that initial aortic valve replacement (AVR) in asymptomatic ...
October 27, 2015 — Results from the multicenter, prospective, randomized PANDA III trial indicate that the BuMA sirolimu ...
October 26, 2015 — OrbusNeich announced the presentation of the one-year clinical outcomes from the 1,000-patient REMEDE ...
October 23, 2015 — Results of the TUXEDO trial, designed to compare two types of stents in diabetic patients, found ...
October 23, 2015 — A randomized trial found that ranolazine did not reduce the composite rate of ischemia-driven ...
October 22, 2015 — Medtronic plc released the first CoreValve transcatheter aortic valve replacement (TAVR) system outco ...
October 22, 2015 — Results from the LEADERS FREE trial found that a polymer-free drug-coated stent (DCS) was superior to ...
October 22, 2015 — Results from the ISAR-DESIRE 4 trial indicate that use of a scoring balloon plus a paclitaxel-coated ...
October 22, 2015 — Direct Flow Medical Inc. announced one-year outcomes from the DISCOVER post-market study that ...
October 21, 2015 — Bracco Diagnostics Inc. announced that Lumason was approved by the Centers for Medicare and Medicaid ...
October 20, 2015 — A pair of studies presented at the 27th annual Transcatheter Cardiovascular Therapeutics (TCT) ...
October 20, 2015 — Results from the BRAVO 3 trial found that bivalirudin did not significantly reduce major bleeding ...